Search Results - "Abaidullah, S"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    Tocilizumab therapy for severely-ill COVID-19 pneumonia patients: a single-centre retrospective study by Iqtadar, S, Khan, A, Mumtaz, S U, Pascual-Figal, D A, Livingstone, S, Abaidullah, S

    “…Systemic hyperinflammation is a hallmark of severe coronavirus disease-2019 (COVID-19). Tocilizumab (TCZ) (an interleukin-6 receptor blocker) therapy is…”
    Get more information
    Journal Article
  2. 2